Advertisement
Clinical Investigation| Volume 364, ISSUE 1, P59-65, July 2022

Prediction model using readily available clinical data for colorectal cancer in a chinese population

  • Author Footnotes
    1 Co-first authors: Jing-yuan Xu, Ya-tao Wang, and Xiao-ling Li contribute equally to the article.
    Jing-yuan Xu
    Footnotes
    1 Co-first authors: Jing-yuan Xu, Ya-tao Wang, and Xiao-ling Li contribute equally to the article.
    Affiliations
    Department of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China
    Search for articles by this author
  • Author Footnotes
    1 Co-first authors: Jing-yuan Xu, Ya-tao Wang, and Xiao-ling Li contribute equally to the article.
    Ya-tao Wang
    Footnotes
    1 Co-first authors: Jing-yuan Xu, Ya-tao Wang, and Xiao-ling Li contribute equally to the article.
    Affiliations
    Department of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China
    Search for articles by this author
  • Author Footnotes
    1 Co-first authors: Jing-yuan Xu, Ya-tao Wang, and Xiao-ling Li contribute equally to the article.
    Xiao-ling Li
    Footnotes
    1 Co-first authors: Jing-yuan Xu, Ya-tao Wang, and Xiao-ling Li contribute equally to the article.
    Affiliations
    Department of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China
    Search for articles by this author
  • Yong Shao
    Affiliations
    Community Health Service Center of Jinxi Town, Kunshan 215300, China
    Search for articles by this author
  • Zhi-yi Han
    Affiliations
    Karamay Central Hospital of Xinjiang, Karamay 834000, China
    Search for articles by this author
  • Jie Zhang
    Affiliations
    Department of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China
    Search for articles by this author
  • Long-bao Yang
    Affiliations
    Department of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China
    Search for articles by this author
  • Jiang Deng
    Affiliations
    Department of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China
    Search for articles by this author
  • Ting Li
    Affiliations
    Department of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China
    Search for articles by this author
  • Ting Wu
    Affiliations
    Community Health Service Center of Jinxi Town, Kunshan 215300, China
    Search for articles by this author
  • Xiao-lan Lu
    Correspondence
    Corresponding authors.
    Affiliations
    Department of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China

    Department of Gastroenterology, Shanghai Pudong Hospital of Fudan University, Shanghai 201399, China
    Search for articles by this author
  • Yan Cheng
    Correspondence
    Corresponding authors.
    Affiliations
    Department of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China
    Search for articles by this author
  • Author Footnotes
    1 Co-first authors: Jing-yuan Xu, Ya-tao Wang, and Xiao-ling Li contribute equally to the article.
Published:February 01, 2022DOI:https://doi.org/10.1016/j.amjms.2022.01.011

      Abstract

      Background

      In China, health screening has become common, although colonoscopy is not always available or acceptable. We sought to develop a prediction model of colorectal cancer (CRC) for health screening population based on readily available clinical data to reduce labor and economic costs.

      Methods

      We conducted a cross-sectional study based on a health screening population in Karamay Central Hospital. By collecting clinical data and basic information from participants, we identified independent risk factors and established a prediction model of CRC. Internal and external validation, calibration plot, and decision curve analysis were employed to test discriminating ability, calibration ability, and clinical practicability.

      Results

      Independent risk factors of CRC, which were readily available in primary public health institutions, included high-density lipoprotein cholesterol, male sex, total cholesterol, advanced age, and hemoglobin. These factors were successfully incorporated into the prediction model (AUC 0.740, 95% CI 0.713-0.767). The model demonstrated a high degree of discrimination and calibration, in addition to a high degree of clinical practicability in high-risk people.

      Conclusions

      The prediction model exhibits good discrimination and calibration and is pragmatic for CRC screening in rural areas and primary public health institutions.

      Key Indexing Terms

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bray F
        • Ferlay J
        • Soerjomataram I
        • et al.
        Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
        CA Cancer J Clin. 2018; 68: 394-424
        • Rex DK
        • Johnson DA
        • Anderson JC
        • et al.
        American College of Gastroenterology guidelines for colorectal cancer screening 2008.
        Am J Gastroenterol. 2009; 104: 739-750
        • Amir Q
        • Denberg TD
        • Hopkins RH
        • et al.
        Screening for colorectal cancer: a guidance statement from the American College of Physicians.
        Ann Intern Med. 2012; 156: 378-386
        • Chen C
        • Stock C
        • Hoffmeister M
        • et al.
        Public health impact of colonoscopy use on colorectal cancer mortality in Germany and the United States.
        Gastrointest Endosc. 2017; 87 (e2): 213-221
        • Click B
        • Pinsky PF
        • Hickey T
        • et al.
        Association of colonoscopy adenoma findings with long-term colorectal cancer incidence.
        JAMA. 2018; 319: 2021-2031
        • Cross AJ
        • Wooldrage K
        • Robbins EC
        • et al.
        Faecal immunochemical tests (FIT) versus colonoscopy for surveillance after screening and polypectomy: a diagnostic accuracy and cost-effectiveness study.
        Gut. 2019; 68: 1642-1652
        • Chen HD
        • Li N
        • Ren JS
        • et al.
        Compliance rate of screening colonoscopy and its associated factors among high-risk populations of colorectal cancer in urban China.
        Zhonghua Yu Fang Yi Xue Za Zhi. 2018; 52: 231-237
        • Tao S
        • Hoffmeister M
        • Brenner H.
        Development and validation of a scoring system to identify individuals at high risk for advanced colorectal neoplasms who should undergo colonoscopy screening.
        Clin Gastroenterol Hepatol. 2014; 12: 478-485
        • Freedman AN
        • Slattery ML
        • Ballard-Barbash R
        • et al.
        Colorectal cancer risk prediction tool for white men and women without known susceptibility.
        J Clin Oncol. 2009; 27: 686-693
        • Park Y
        • Freedman AN
        • Gail MH
        • et al.
        Validation of a colorectal cancer risk prediction model among white patients age 50 years and older.
        J Clin Oncol. 2009; 27: 694-698
        • Lebwohl B
        • Capiak K
        • Neugut AI
        • et al.
        Risk of colorectal adenomas and advanced neoplasia in H ispanic, black and white patients undergoing screening colonoscopy.
        Aliment Pharmacol Ther. 2012; 35: 1467-1473
        • Cai Q-C
        • Yu E-D
        • Xiao Y
        • et al.
        Derivation and validation of a prediction rule for estimating advanced colorectal neoplasm risk in average-risk Chinese.
        Am J Epidemiol. 2012; 175: 584-593
        • Chen G
        • Mao B
        • Pan Q
        • et al.
        Prediction rule for estimating advanced colorectal neoplasm risk in average-risk populations in southern Jiangsu Province.
        Chin J Cancer Res. 2014; 26: 4-11
        • Wang H-M
        • Chang T-H
        • Lin F-M
        • et al.
        A new method for post Genome-Wide Association Study (GWAS) analysis of colorectal cancer in Taiwan.
        Gene. 2013; 518: 107-113
        • Li J
        • Chang J
        • Zhu Y
        • et al.
        Risk prediction of colorectal cancer with common genetic variants and conventional non-genetic factors in a Chinese Han population.
        Zhonghua Liu Xing Bing Xue Za Zhi. 2015; 36: 1053-1057
        • Hanley JA
        • McNeil BJ.
        The meaning and use of the area under a receiver operating characteristic (ROC) curve.
        Radiology. 1982; 143: 29-36
        • Johnson RW.
        An introduction to the bootstrap.
        Teach Stat. 2001; 23: 49-54
        • Steyerberg EW
        • Bleeker SE
        • Moll HA
        • et al.
        Internal and external validation of predictive models: a simulation study of bias and precision in small samples.
        J Clin Epidemiol. 2003; 56: 441-447
        • Schroy PC
        • Wong JB
        • O'Brien MJ
        • et al.
        A risk prediction index for advanced colorectal neoplasia at screening colonoscopy.
        Am J Gastroenterol. 2015; 110: 1062-1071
        • Vickers AJ
        • Cronin AM
        • Elkin EB
        • et al.
        Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers.
        BMC Med Inform Decis Mak. 2008; 8: 53
        • Kerr KF
        • Brown MD
        • Zhu K
        • et al.
        Assessing the clinical impact of risk prediction models with decision curves: guidance for correct interpretation and appropriate use.
        J Clin Oncol. 2016; 34: 2534-2540
        • Goldshtein I
        • Neeman U
        • Chodick G
        • et al.
        Variations in hemoglobin before colorectal cancer diagnosis.
        Eur J Cancer Prev. 2010; 19: 342-344
        • Lieberman DA
        • Holub J
        • Eisen G
        • et al.
        Prevalence of polyps greater than 9 mm in a consortium of diverse clinical practice settings in the United States.
        Clin Gastroenterol Hepatol. 2005; 3: 798-805
        • Nguyen SP
        • Bent S
        • Chen Y-H
        • et al.
        Gender as a risk factor for advanced neoplasia and colorectal cancer: a systematic review and meta-analysis.
        Clin Gastroenterol Hepatol. 2009; 7: 676-681
        • Ma E
        • Sasazuki S
        • Iwasaki M
        • et al.
        10-Year risk of colorectal cancer: development and validation of a prediction model in middle-aged Japanese men.
        Cancer Epidemiol. 2010; 34: 534-541
        • Driver JA
        • Gaziano JM
        • Gelber RP
        • et al.
        Development of a risk score for colorectal cancer in men.
        Am J Med. 2007; 120: 257-263
        • Lin OS
        • Kozarek RA
        • Schembre DB
        • et al.
        Risk stratification for colon neoplasia: screening strategies using colonoscopy and computerized tomographic colonography.
        Gastroenterology. 2006; 131: 1011-1019
        • Imperiale TF
        • Wagner DR
        • Lin CY
        • et al.
        Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer.
        Ann Intern Med. 2003; 139: 959-965
        • Levitzky BE
        • Brown CC
        • Heeren TC
        • et al.
        Performance of a risk index for advanced proximal colorectal neoplasia among a racially/ethnically diverse patient population (risk index for advanced proximal neoplasia).
        Am J Gastroenterol. 2011; 106: 1099-1106
        • Colangelo LA
        • Gapstur SM
        • Gann PH
        • et al.
        Colorectal cancer mortality and factors related to the insulin resistance syndrome.
        Cancer Epidemiol Prevent Biomarkers. 2002; 11: 385-391
        • Jaggers JR
        • Sui X
        • Hooker SP
        • et al.
        Metabolic syndrome and risk of cancer mortality in men.
        Eur J Cancer. 2009; 45: 1831-1838
        • Yang Y
        • Mauldin PD
        • Ebeling M
        • et al.
        Effect of metabolic syndrome and its components on recurrence and survival in colon cancer patients.
        Cancer. 2013; 119: 1512-1520
        • Cheung KS
        • Chen L
        • Seto WK
        • et al.
        Epidemiology, characteristics, and survival of post-colonoscopy colorectal cancer in Asia: a population-based study.
        J Gastroenterol Hepatol. 2019; 34: 1545-1553
        • Keshk WA
        • Zineldeen DH
        • El-Khadrawy OH.
        Fatty acid synthase/oxidized low-density lipoprotein as metabolic oncogenes linking obesity to colon cancer via NF-kappa B in Egyptians.
        Med Oncol. 2014; 31: 192
        • Mihajlovic M
        • Gojkovic T
        • Vladimirov S
        • et al.
        Changes in lecithin: cholesterol acyltransferase, cholesteryl ester transfer protein and paraoxonase-1 activities in patients with colorectal cancer.
        Clin Biochem. 2019; 63: 32-38
        • Ma GK
        • Ladabaum U.
        Personalizing colorectal cancer screening: a systematic review of models to predict risk of colorectal neoplasia.
        Clin Gastroenterol Hepatol. 2014; 12 (e1): 1624-1634
        • Wei EK
        • Colditz GA
        • Giovannucci EL
        • et al.
        Cumulative risk of colon cancer up to age 70 years by risk factor status using data from the Nurses’ Health Study.
        Am J Epidemiol. 2009; 170: 863-872
        • Lieberman DA
        • Williams JL
        • Holub JL
        • et al.
        Race, ethnicity, and sex affect risk for polyps>9 mm in average-risk individuals.
        Gastroenterology. 2014; 147: 351-358
        • Steyerberg EW
        • Vergouwe Y.
        Towards better clinical prediction models: seven steps for development and an ABCD for validation.
        Eur Heart J. 2014; 35: 1925-1931
        • Su T-L
        • Jaki T
        • Hickey GL
        • et al.
        A review of statistical updating methods for clinical prediction models.
        Stat Methods Med Res. 2018; 27: 185-197